Origene™ Genetic Screening
Chimeric Antigen Receptor (CAR T-Cell) is a new form of compassionate-use cancer immunotherapy with the following benefits:
- Enable recognition and targeting of specific cancer cells
- Reduce side effects from treatment, as healthy cells are left undamaged
- Safer for late-stage cancers or when usual treatment fails